This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. Popular weight loss drugs Ozempic and ...
California just cut off access to critical anti-obesity drugs for hundreds of thousands of patients. Under the new budget signed by Gov. Gavin Newsom, Medi-Cal — the state’s Medicaid program — would ...
Revolutionizing Medical Weight Loss with GLP-1 Therapy Bellingham, United States - February 25, 2026 / Mt. Baker ...
California just cut off access to critical anti-obesity drugs for hundreds of thousands of patients. Under the new budget signed by Gov. Gavin Newsom, Medi-Cal — the state’s Medicaid program — would ...
The conversation around weight loss has changed dramatically over the past few years. Medications such as semaglutide and tirzepatide—often referred to as GLP-1 therapies—have dominated headlines, ...
This story was originally published by CalMatters. Sign up for their newsletters. Popular weight loss drugs Ozempic and Wegovy would no longer be covered by Medi-Cal under a proposal unveiled by Gov.
Popular weight loss drugs Ozempic and Wegovy would no longer be covered by Medi-Cal under a proposal unveiled by Gov. Gavin Newsom Wednesday in an effort to reduce cost overruns in the state health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results